AA

Arun Ahuja

Active Director Director DIN 10364460
DIN 10364460 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Arun Ahuja

Data last updated:

Arun Ahuja is a Director at Mirakare Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Mirakare Pharmaceuticals Private Limited reported revenue of ₹84,739 (FY 2024).

DIN 10364460
Primary Designation Director
Industry Pharma
First Appointment 19 Oct 2023
Oldest Company Age 3 yrs
Largest company Mirakare Pharmaceuticals Private Limited · ₹84,739 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Oct 20232023₹84,739 (FY 2024)Active

Board colleagues of Arun Ahuja

NameDINCompanyDesignation
Ramesh Rupaal10364459Mirakare Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mirakare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arun Ahuja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Ahuja

Arun Ahuja currently holds 1 directorship: Mirakare Pharmaceuticals Private Limited (Director, since 19 Oct 2023, revenue ₹84,739 (FY 2024)).

Arun Ahuja was first appointed on 19 Oct 2023 as Director at Mirakare Pharmaceuticals Private Limited.

The current boards of Arun Ahuja's companies include Ramesh Rupaal (Mirakare Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available